DaSH Global

A leading real-world research company. Supporting the drug approval process by delivering cost-efficient, timely & unique real-world research data.

[DaSH Global @DaSHGlobal2]

#NICE in the #UK has indicated in its 2021-2026 Transformation Plan that the use of #RealWorldEvidence as outlined in the framework document (https://t.co/umZID3Qr1d) can improve our understanding of #health and #SocialCare and the effects of interventions on #patient outcomes.

[DaSH Global @DaSHGlobal2]

Contact [email protected] to discover how Patient Reported Outcome Measures (PROMs) drive change in treatments and care.

#HealthcareData #MedicalResearch #PatientData #CancerResearch #ClinicalTrials #DrugDevelopment #PatientMonitoring #HEOR #RealWorldEvidence #DigitalHealth

[DaSH Global @DaSHGlobal2]

Developed by DaSH Global, the Your Health Companion is underpinned by the globally recognised Patient Reported Outcomes Measures (PROMs).

Contact us on [email protected] to discover how we can enhance your clinical research program.

#DrugDiscovery #ClinicalResearch #Pharma

[DaSH Global @DaSHGlobal2]

All data collected by DaSH Global is anonymised.

Research teams are able to make applications to use this data.

We ensure these organisations meet the highest data protection standards.

[email protected]

#RealWorldEvidence #HealthData #HealthTechnology #Pharma

[DaSH Global @DaSHGlobal2]

Your Health Companion provides insight into experience of care, quality of life, symptoms, and clinical management of Mesothelioma.

Contact us on:
[email protected]

#RealWorldEvidence #HealthEconomics #OutcomesResearch #RWD #Pharma #MarketAccess #PatientExperience #Insight

[HASAG Asbestos Disease Support @Team_HASAG]

Our next #Berkshire coffee morning is at 11AM tomorrow! See you there for a coffee and catch up ☕🍩@mesouk #charity #mesothelioma #support #asbestos #HASAG

[London Asbestos Support Awareness Group @LASAG_UK]

Great day 1 of raising asbestos awareness #asbestos #mesothelioma @LondonLabour #CapeMustPay

[UKALK+ @UKALK1]

Volunteer Opportunity: Join Our Medical & Scientific Advisory Panel

ALK+ UK is looking for healthcare professionals or scientists, ideally with an interest in ALK-positive lung cancer, to join our advisory panel.

This is a voluntary role, where your expertise will help shape our work in supporting patients, reviewing publications, and advising on clinical trials.

If you’re a current or retired professional and can offer up to 10 hours a month, we’d love to hear from you.

ALK-positive lung cancer is a relatively rare form of lung cancer that often affects younger people who are non-smokers.

ALK Positive Lung Cancer UK UK is a registered charity that provides support and empowerment to ALK-positive lung cancer patients. We also advocate for best practices throughout the UK and campaign for early diagnosis of non-smoking lung cancer. @rcgp @BTOGORG @LCN_UK @UKlungcancer

[Lung Cancer Policy Network @LungPolicy]

Establishing consensus-driven pathways places people with #LungCancer at the heart of care. Watch our recent webinar to discover more about how care pathways can be implemented. #LCSM
https://t.co/NjkFTqMqUZ

[DaSH Global @DaSHGlobal2]

2nd article from Lee Wemyss at DaSH global looking at why we hear so little about PROMs

https://t.co/2OnoMnMyTo

#RWE #RWD #HEOR #CancerResearch #DrugDevelopment #NHS #Pharma

[DaSH Global @DaSHGlobal2]

Check out this new article from Lee Wemyss at DaSH Global discussing important issues around the use of Patient Reported Outcome Measures (PROMs).

https://t.co/QNUJUcDwpR

#RWE #RWD #HEOR #CancerResearch #DrugDevelopment #NHS #Pharma

[DaSH Global @DaSHGlobal2]

Discover more https://t.co/oZd2wXmehO Contact us on [email protected]

#RealWorldEvidence #QualitativeInsights #HealthEconomics #OutcomesResearch #HealthcareInfomatics #HealthTechnology #HealthData #HEOR #RWE #RWD #Pharma #MarketAccess #Insights #PatientExperience

[DaSH Global @DaSHGlobal2]

The Digital Assessment Xchange (DAX) is an integrated healthcare research platform for the outcomes assessment of patients with cancers.

https://t.co/FtiRZT7OQ0

#HealthcareResearch #LungCancer #Mesothelioma #HEOR #Pharma #drugdiscovery
@Mesouk @Team_HASAG @LCN_UK

[DaSH Global @DaSHGlobal2]

DaSH Global are to launch a new platform in Haematological Cancers.

Talk to us at ESMO in Barcelona to find out more:
[email protected]

#DrugDiscovery #ClinicalResearch #Pharma #CancerResearch #RWE #HEOR #Haematology #ESMO2024 #MedicalAffairs #PatientAdvocacy #BloodCancers

[DaSH Global @DaSHGlobal2]

Developed in association with #MesotheliomaUK, Your Health Companion seeks to compliment the work of the major #PatientSupportGroups and #CancerCharities to improve the lives of patients.

[email protected]

#MedicalResearch #CancerResearch #PatientOutcomes #HEOR #RWE

[DaSH Global @DaSHGlobal2]

DaSH Global senior management will be attending the ESMO meeting in Barcelona in September.

Contact [email protected] to meet with us

#DrugDiscovery #MarketAccess #CancerResearch #RWE #HEOR #Mesothelioma #LungCancer #ESMO2024 #MedicalAffairs

@Team_HASAG @Mesouk @LCN_UK

[DaSH Global @DaSHGlobal2]

DaSH Global are to launching a new platform in Haematological Cancers.

Our team will be attending ESMOin Barcelona. Contact us on [email protected] to meet us there.

#DrugDiscovery #ClinicalResearch #CancerResearch #RWE #HEOR #HealthData #Haematology #ESMO2024 #BloodCancers

[DaSH Global @DaSHGlobal2]

The King's Fund believes that the use of #PROMs will improve delivery of care to patients and help health commissioners assess value for money when considering new treatments.

#HealthcareDelivery #HealthCommissioning #CancerCare #Pharma #MedicalResearch #RealWorldData #RWE #HEOR

[DaSH Global @DaSHGlobal2]

DaSH Global will be attending ESMO in Barcelona in September.

Contact us on [email protected] to book a meeting with us.

#ClinicalResearch #Pharma #CancerResearch #RWE #HEOR #OutcomesResearch #Mesothelioma #LungCancer #ESMO2024 #MedicalAffairs #BloodCancers #PatientAdvocacy

[DaSH Global @DaSHGlobal2]

NICE has indicated that the use of Real World Evidence can improve understanding of the effects of interventions on patient outcomes.

Contact [email protected]

#NICE #TransformationPlan #RWE #PatientOutcomes #Healthcare #NHS #LungCancer #Mesothelioma #Pharma #MarketAccess